Onconetix logo

Onconetix share price today

(ONCO)

Onconetix share price is $0.35 & ₹29.74 as on 21 Dec 2024, 2.30 'hrs' IST

$0.35

-0.01

(-3.64%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Onconetix share price in Dollar and Rupees. Guide to invest in Onconetix from India. Also see the sentimental analysis on Indian investors investing in Onconetix. Get details on the Indian mutual funds that are investing in Onconetix. Get Analyst recommendations and forecasts along with all the Onconetix's financials.

Onconetix share price movements

  • Today's Low: $0.35
    Today's High: $0.38

    Day's Volatility :7.89%

  • 52 Weeks Low: $0.35
    52 Weeks High: $21.40

    52 Weeks Volatility :98.38%

Onconetix Returns

PeriodOnconetix IncIndex (Russel 2000)
3 Months
-88.31%
0.0%
6 Months
-93.99%
0.0%
1 Year
-95.87%
0.0%
3 Years
-99.4%
-19.7%

Onconetix Key Statistics

in dollars & INR

Previous Close
$0.36
Open
$0.36
Today's High
$0.379999
Today's Low
$0.35
Market Capitalization
$2.9M
Today's Volume
$330.9K
52 Week High
$21.4
52 Week Low
$0.3469
Revenue TTM
$1.5M
EBITDA
$-15.1M
Earnings Per Share (EPS)
$-87.25
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1758.48%

How to invest in Onconetix from India?

It is very easy for Indian residents to invest directly in Onconetix from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Onconetix stock in both Indian Rupees (INR) and US Dollars (USD). Search for Onconetix or ONCO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Onconetix or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Onconetix shares which would translate to 2.428 fractional shares of Onconetix as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Onconetix, in just a few clicks!

Returns in Onconetix for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Onconetix investment value today

Current value as on today

₹1,98,029

Returns

₹98,029

(+98.03%)

Returns from Onconetix Stock

₹95,833 (false-95.83%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Onconetix

113%

Period: Sep 22, 2024 to Dec 21, 2024. Change in 30 Days versus previous period

Search volume for Onconetix on INDmoney from India has grown in the last 30 days as on Dec 22, 2024. 113% more investors are searching Onconetix in the last 30 days versus the previous period.

Analyst Recommendation on Onconetix

Sell

    0%Buy

    50%Hold

    50%Sell

Based on 6 Wall street analysts offering stock ratings for Onconetix(by analysts ranked 0 to 5 stars)

Based on 6 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
0
0
0
Hold
3
3
3
Sell
3
3
3

Analyst Forecast on Onconetix

What analysts predicted

Upside of 2471.43%

Current:

$0.35

Target:

$9.00

Insights on Onconetix

  • Price Movement

    In the last 7 days, ONCO stock has moved down by -13.7%

Onconetix Technicals Summary

Sell

Neutral

Buy

Onconetix is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Onconetix Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Onconetix Inc
-68.17%
-93.99%
-95.87%
-99.4%
-99.4%
Regeneron Pharmaceuticals, Inc.
-5.73%
-34.03%
-17.38%
12.23%
86.41%
Biontech Se
4.48%
30.56%
7.97%
-55.71%
237.85%
Alnylam Pharmaceuticals, Inc.
-0.55%
10.11%
28.37%
26.29%
108.55%
Vertex Pharmaceuticals Incorporated
-11.79%
-16.36%
-2.55%
77.79%
80.12%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Onconetix Inc
NA
NA
NA
0.0
-17.58
-0.22
NA
-10.04
Regeneron Pharmaceuticals, Inc.
17.51
17.51
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.55
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Onconetix Inc
Sell
$2.9M
-99.4%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$77.8B
86.41%
17.51
33.61%
Biontech Se
Buy
$26.7B
237.85%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.8B
108.55%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$102.1B
80.12%
32.84
-4.51%

About Onconetix

developed by scientists at the prestigious oxford university in the uk, our vaccine protects against all influenza strains. it targets parts of the virus that are easy to induce a protective immune response against but also limited in variability. these regions of the virus were shown in thompson et al 2018 to direct the antigenic evolution of the influenza virus and therefore make ideal vaccine targets. the vaccine thus negates the need for (i) annual vaccination, providing potentially life-long protection against flu, and (ii) reformulation of the vaccine every few years.
Organization
Onconetix
Employees
12
CEO
Dr. Ralph Schiess Ph.D.
Industry
Miscellaneous

Management People of Onconetix

NameTitle
Dr. Ralph Schiess Ph.D.
Interim CEO & Chief Science Officer
Ms. Karina M. Fedasz
Interim Chief Financial Officer
Dr. Brian Price Ph.D.
Head of Technology Strategy
Mr. Andrew D. Skibo Ph.D.
Global Head of Biologics Operations
Mr. Theodore Scott Yoho
Head of Business Development
Dr. Ali I. Fattom Ph.D.
Head of Science & Discovery
Dr. Jay Newmark M.B.A., M.D.
Chief Medical Officer
Mr. Christian Bruhlmann
Chief Strategy Officer & GM of Europe
Dr. Donald L. Very Jr., Ph.D.
Senior VP of Commercial Research & Development

Important FAQs about investing in Onconetix from India :

What is Onconetix share price today?

Onconetix share price today stands at $0.35, Open: $0.36 ; Previous Close: $0.36 ; High: $0.38 ; Low: $0.35 ; 52 Week High: $21.40 ; 52 Week Low: $0.35. The stock opens at $0.36, after a previous close of $0.36. The stock reached a daily high of $0.38 and a low of $0.35, with a 52-week high of $21.40 and a 52-week low of $0.35.

Can Indians buy Onconetix shares?

Yes, Indians can invest in the Onconetix (ONCO) from India.

With INDmoney, you can buy Onconetix at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Onconetix at zero transaction cost.

How can I buy Onconetix shares from India?

It is very easy to buy Onconetix from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Onconetix be purchased?

Yes, you can buy fractional shares of Onconetix with INDmoney app.

What are the documents required to start investing in Onconetix stocks?

To start investing in Onconetix, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Onconetix

Today’s highest price of Onconetix (ONCO) is $0.38.

Today’s lowest price of Onconetix (ONCO) is $0.35.

What is today's market capitalisation of Onconetix

Today's market capitalisation of Onconetix ONCO is 2.9M

What is the 52 Week High and Low Range of Onconetix

  • 52 Week High

    $21.40

  • 52 Week Low

    $0.35

What are the historical returns of Onconetix?

  • 1 Month Returns

    -68.17%

  • 3 Months Returns

    -93.99%

  • 1 Year Returns

    -95.87%

  • 5 Years Returns

    -99.4%

Who is the Chief Executive Officer (CEO) of Onconetix

Dr. Ralph Schiess Ph.D. is the current Chief Executive Officer (CEO) of Onconetix.